Fuhrman Alan has filed 10 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 1376 shares of Tyra Biosciences, Inc. ($TYRA) on March 13, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Tyra Biosciences, Inc. | $TYRA | Fuhrman Alan | Chief Financial Officer | A | Common Stock | 1376 | $9.13 | 16,164.0000 | 59,670,757 | 9.30% | 0.00% |
| Sept. 15, 2025 | Tyra Biosciences, Inc. | $TYRA | Fuhrman Alan | Chief Financial Officer | A | Common Stock | 701 | $9.13 | 14,788.0000 | 57,217,746 | 4.98% | 0.00% |
| Aug. 7, 2025 | Tyra Biosciences, Inc. | $TYRA | Fuhrman Alan | Chief Financial Officer | A | Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 57,217,746 | 9999.99% | 0.30% |
| March 14, 2025 | Tyra Biosciences, Inc. | $TYRA | Fuhrman Alan | Chief Financial Officer | A | Common Stock | 1238 | $9.78 | 14,087.0000 | 57,217,746 | 9.63% | 0.00% |
| Oct. 30, 2024 | Tyra Biosciences, Inc. | $TYRA | Fuhrman Alan | Chief Financial Officer | P | Common Stock | 9500 | $16.00 | 12,849.0000 | 58,874,497 | 283.67% | 0.02% |
| Sept. 13, 2024 | Tyra Biosciences, Inc. | $TYRA | Fuhrman Alan | Chief Financial Officer | A | Common Stock | 954 | $12.48 | 3,349.0000 | 42,704,876 | 39.83% | 0.00% |
| Aug. 14, 2024 | Tyra Biosciences, Inc. | $TYRA | Fuhrman Alan | Chief Financial Officer | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 42,704,876 | 9999.99% | 0.27% |
| May 23, 2024 | Esperion Therapeutics, Inc. | $ESPR | Fuhrman Alan | Director | A | Common Stock | 23000 | $0.00 | 53,404.0000 | 0 | 75.65% | 0.00% |
| May 23, 2024 | Esperion Therapeutics, Inc. | $ESPR | Fuhrman Alan | Director | A | Stock Option (right to buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2024 | Tyra Biosciences, Inc. | $TYRA | Fuhrman Alan | Chief Financial Officer | A | Common Stock | 932 | $12.48 | 2,395.0000 | 42,704,876 | 63.70% | 0.00% |